Clinical Trials Browser

Phase 2 × Usual Type Vulval Intraepithelial Neoplasia (uVIN) × Clear all

NCT02596074 2017-08-03

Pharmacodynamics, Safety/Tolerability and Efficacy of Topical Omiganan in Patients With uVIN

Phase 2 Completed

Usual Type Vulval Intraepithelial Neoplasia (uVIN)